Italian Register for the Study of Complicated Intra-Abdominal Infections

Italian Register for the Study of Complicated Intra-Abdominal Infections (IRCA) Study

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03678298

Acronym

IRCA

Enrollment

1000

Registered

2018-09-19

Start date

2019-01-01

Completion date

2020-04-01

Last updated

2018-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complicated Intra-abdominal Infections

Brief summary

The study will identify the epidemiological and treatment profiles of acute peritonitis in Italy

Detailed description

The primary objectives of the study are: (1) the identification of specific risk factors for in-hospital mortality, in order to perfect the clinical management of patients with complicated intra-abdominal infections (cIAIs); (2) the identification of specific risk factors for multi-drug resistant organisms (MDROs) isolation in patients with cIAIs, in order to improve the adequacy of empirical antimicrobial therapy. The secondary objectives are: (1) the description of the clinical, diagnostic and treatment profiles of patients with cIAIs in Italian surgical departments; (2) the analysis of epidemiology and patterns of antimicrobial susceptibility of the microorganisms isolated in samples in intra-operative samples of peritoneal fluid or purulent exudate/discrete abscesses in patients with cIAIs; (3) the identification of specific risk factors for post-operative complications in patients with cIAIs.

Interventions

OTHEREpidemiological/treatment profiles

All consecutively hospitalized adult patients (older than 18 years of age) undergoing surgery, interventional drainage or conservative treatment, with diagnosis of cIAIs (defined as abdominal infections originating in an organ cavity, extending into the peritoneal space, and forming an abscess or peritonitis, will be included in the study.

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 110 Years

Inclusion criteria

Exclusion criteria

Patients younger than 16 years-old, patients with pancreatitis or primary peritonitis

Design outcomes

Primary

Measure	Time frame
Mortality rates linked to different sources of infection	12 months
Mortality rates linked to different bacteria causing infection	12 months

Countries

Italy

Contacts

Primary ContactMassimo Sartelli, MD

massimosartelli@gmail.com00393405369701

Backup ContactFausto Catena, MD

faustocatena@gmail.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026